|
[1]
|
Yap, D.Y.H. and Lai, K.N. (2010) Cytokines and Their Roles in the Pathogenesis of Systemic Lupus Erythematosus: From Basics to Recent Advances. Journal of Biomedicine and Biotechnology, 2010, Article ID: 365083. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mok, C.C. (2010) Biomarkers for Lupus Nephritis: A Critical Appraisal. Journal of Biomedicine and Biotechnology, 2010, Article ID: 638413. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Andrade, S.d.O., Julio, P.R., Nunes de Paula Ferreira, D. and Appenzeller, S. (2021) Predicting Lupus Flares: Epidemiological and Disease Related Risk Factors. Expert Review of Clinical Immunology, 17, 143-153. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Parikh, S.V., Nagaraja, H.N., Hebert, L. and Rovin, B.H. (2014) Renal Flare as a Predictor of Incident and Progressive CKD in Patients with Lupus Nephritis. Clinical Journal of the American Society of Nephrology, 9, 279-284. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Tamirou, F. and Houssiau, F.A. (2021) Management of Lupus Nephritis. Journal of Clinical Medicine, 10, Article No. 670. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Gensous, N., Marti, A., Barnetche, T., Blanco, P., Lazaro, E., Seneschal, J., et al. (2017) Predictive Biological Markers of Systemic Lupus Erythematosus Flares: A Systematic Literature Review. Arthritis Research & Therapy, 19, Article No. 238. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Bertsias, G.K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J.H.M., et al. (2012) Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) Recommendations for the Management of Adult and Paediatric Lupus Nephritis. Annals of the Rheumatic Diseases, 71, 1771-1782. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Fine, D.M., Ziegenbein, M., Petri, M., Han, E.C., McKinley, A.M., Chellini, J.W., et al. (2009) A Prospective Study of Protein Excretion Using Short-Interval Timed Urine Collections in Patients with Lupus Nephritis. Kidney International, 76, 1284-1288. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Birmingham, D., Irshaid, F., Nagaraja, H., Zou, X., Tsao, B., Wu, H., et al. (2010) The Complex Nature of Serum C3 and C4 as Biomarkers of Lupus Renal Flare. Lupus, 19, 1272-1280. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., et al. (1995) Prevention of Relapses in Systemic Lupus Erythematosus. The Lancet, 345, 1595-1599. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ho, A., Magder, L.S., Barr, S.G. and Petri, M. (2001) Decreases in Anti-Double-Stranded DNA Levels Are Associated with Concurrent Flares in Patients with Systemic Lupus Erythematosus. Arthritis & Rheumatism, 44, 2342-2349. [Google Scholar] [CrossRef]
|
|
[12]
|
Pan, N., Amigues, I., Lyman, S., Duculan, R., Aziz, F., Crow, M., et al. (2013) A Surge in Anti-dsDNA Titer Predicts a Severe Lupus Flare within Six Months. Lupus, 23, 293-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Binder, E. and Edelbauer, M. (2013) Use of Biomarkers in the Management of Children with Lupus. Current Rheumatology Reports, 15, Article No. 312. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Watson, L. and Beresford, M.W. (2012) Urine Biomarkers in Juvenile-Onset SLE Nephritis. Pediatric Nephrology, 28, 363-374. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Welch, T.R. and Blystone, L.W. (2009) Renal Disease Associated with Inherited Disorders of the Complement System. Pediatric Nephrology, 24, 1439-1444. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Moroni, G., Quaglini, S., Radice, A., Trezzi, B., Raffiotta, F., Messa, P., et al. (2015) The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy. Journal of Immunology Research, 2015, Article ID: 106904. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Orbai, A., Truedsson, L., Sturfelt, G., Nived, O., Fang, H., Alarcón, G.S., et al. (2014) Anti-c1q Antibodies in Systemic Lupus Erythematosus. Lupus, 24, 42-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Norsworthy, P. and Davies, K.A. (2003) Complement Components and Their Autoantibodies. Molecular Biotechnology, 23, 259-270. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Calatroni, M., Moroni, G., Conte, E., Stella, M., Reggiani, F. and Ponticelli, C. (2024) Anti-c1q Antibodies: A Biomarker for Diagnosis and Management of Lupus Nephritis. A Narrative Review. Frontiers in Immunology, 15, Article ID: 1410032. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Akhter, E., Burlingame, R., Seaman, A., Magder, L. and Petri, M. (2011) Anti-c1q Antibodies Have Higher Correlation with Flares of Lupus Nephritis than Other Serum Markers. Lupus, 20, 1267-1274. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Moroni, G., Trendelenburg, M., Del Papa, N., Quaglini, S., Raschi, E., Panzeri, P., et al. (2001) Anti-c1q Antibodies May Help in Diagnosing a Renal Flare in Lupus Nephritis. American Journal of Kidney Diseases, 37, 490-498. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Cai, X., Yang, X., Lian, F., Lin, X., Liang, M., Li, J., et al. (2010) Correlation between Serum Anti-C1q Antibody Levels and Renal Pathological Characteristics and Prognostic Significance of Anti-C1q Antibody in Lupus Nephritis. The Journal of Rheumatology, 37, 759-765. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Tucci, M., Barnes, E.V., Sobel, E.S., Croker, B.P., Segal, M.S., Reeves, W.H., et al. (2004) Strong Association of a Functional Polymorphism in the Monocyte Chemoattractant Protein 1 Promoter Gene with Lupus Nephritis. Arthritis & Rheumatism, 50, 1842-1849. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Tian, S., Li, J., Wang, L., Liu, T., Liu, H., Cheng, G., et al. (2007) Urinary Levels of RANTES and M-CSF Are Predictors of Lupus Nephritis Flare. Inflammation Research, 56, 304-310. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Schwartz, N., Su, L., Burkly, L.C., Mackay, M., Aranow, C., Kollaros, M., et al. (2006) Urinary TWEAK and the Activity of Lupus Nephritis. Journal of Autoimmunity, 27, 242-250. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Adhya, Z., Borozdenkova, S. and Karim, M.Y. (2011) The Role of Cytokines as Biomarkers in Systemic Lupus Erythematosus and Lupus Nephritis. Nephrology Dialysis Transplantation, 26, 3273-3280. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Dong, X., Zheng, Z., Luo, X., Ding, J., Li, Y., Li, Z., et al. (2018) Combined Utilization of Untimed Single Urine of MCP-1 and TWEAK as a Potential Indicator for Proteinuria in Lupus Nephritis. Medicine, 97, e0343. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Moloi, M.W., Rusch, J.A., Omar, F., Ekrikpo, U., Dandara, C., Bello, A.K., et al. (2021) Urinary MCP-1 and TWEAK as Non-Invasive Markers of Disease Activity and Treatment Response in Patients with Lupus Nephritis in South Africa. International Urology and Nephrology, 53, 1865-1873. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Costa-Reis, P., Maurer, K., Petri, M.A., Levy Erez, D., Zhao, X., Faig, W., et al. (2022) Urinary HER2, TWEAK and VCAM-1 Levels Are Associated with New-Onset Proteinuria in Paediatric Lupus Nephritis. Lupus Science & Medicine, 9, e000719. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Rovin, B.H., Song, H., Hebert, L.A., Nadasdy, T., Nadasdy, G., Birmingham, D.J., et al. (2005) Plasma, Urine, and Renal Expression of Adiponectin in Human Systemic Lupus Erythematosus. Kidney International, 68, 1825-1833. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Wulster-Radcliffe, M.C., Ajuwon, K.M., Wang, J., Christian, J.A. and Spurlock, M.E. (2004) Adiponectin Differentially Regulates Cytokines in Porcine Macrophages. Biochemical and Biophysical Research Communications, 316, 924-929. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Neumeier, M., Weigert, J., Schäffler, A., Wehrwein, G., Müller-Ladner, U., Schölmerich, J., et al. (2006) Different Effects of Adiponectin Isoforms in Human Monocytic Cells. Journal of Leukocyte Biology, 79, 803-808. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Rovin, B.H. and Song, H. (2006) Chemokine Induction by the Adipocyte-Derived Cytokine Adiponectin. Clinical Immunology, 120, 99-105. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Diaz-Rizo, V., Bonilla-Lara, D., Gonzalez-Lopez, L., Sanchez-Mosco, D., Fajardo-Robledo, N.S., Perez-Guerrero, E.E., et al. (2017) Serum Levels of Adiponectin and Leptin as Biomarkers of Proteinuria in Lupus Nephritis. PLOS ONE, 12, e0184056. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Brunner, H.I., Gulati, G., Klein-Gitelman, M.S., Rouster-Stevens, K.A., Tucker, L., Ardoin, S.P., et al. (2018) Urine Biomarkers of Chronic Kidney Damage and Renal Functional Decline in Childhood-Onset Systemic Lupus Erythematosus. Pediatric Nephrology, 34, 117-128. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Brunner, H.I., Mueller, M., Rutherford, C., Passo, M.H., Witte, D., Grom, A., et al. (2006) Urinary Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Nephritis in Childhood‐Onset Systemic Lupus Erythematosus. Arthritis & Rheumatism, 54, 2577-2584. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Suzuki, M., Wiers, K.M., Klein-Gitelman, M.S., Haines, K.A., Olson, J., Onel, K.B., et al. (2008) Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Disease Activity in Pediatric Lupus Nephritis. Pediatric Nephrology, 23, 403-412. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wu, C., Yang, M., Zhou, Z., et al. (2015) Urinary Soluble Intercellular Adhesion Molecule-1 and Vascular Cellular Adhesion Molecule-1: Potential Biomarkers of Active Lupus Nephritis. Journal of Southern Medical University, 35, 1272-1276, 1282.
|
|
[39]
|
Howe, H.S., Kong, K.O., Thong, B.Y., Law, W.G., Chia, F.L.A., Lian, T.Y., et al. (2012) Urine sVCAM-1 and sICAM-1 Levels Are Elevated in Lupus Nephritis. International Journal of Rheumatic Diseases, 15, 13-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Robak, E., Woźniacka, A., Sysa-Jedrzejowska, A., et al. (2001) Serum Levels of Angiogenic Cytokines in Systemic Lu-pus Erythematosus and Their Correlation with Disease Activity. European Cytokine Network, 12, 445-452.
|
|
[41]
|
Guan, J., Wang, G., Tam, L., Kwan, B., Li, E., Chow, K., et al. (2012) Urinary Sediment ICAM-1 Level in Lupus Nephritis. Lupus, 21, 1190-1195. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Frank, P.G. and Lisanti, M.P. (2008) ICAM-1: Role in Inflammation and in the Regulation of Vascular Permeability. American Journal of Physiology-Heart and Circulatory Physiology, 295, H926-H927. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Pallis, M., Robson, D.K., Haskard, D.O. and Powell, R.J. (1993) Distribution of Cell Adhesion Molecules in Skeletal Muscle from Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 52, 667-671. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Belmont, H.M., Buyon, J., Giorno, R. and Abramson, S. (1994) Up‐Regulation of Endothelial Cell Adhesion Molecules Characterizes Disease Activity in Systemic Lupus Erythematosus. The Shwartzman Phenomenon Revisited. Arthritis & Rheumatism, 37, 376-383. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Ichimura, T., Bonventre, J.V., Bailly, V., Wei, H., Hession, C.A., Cate, R.L., et al. (1998) Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-Regulated in Renal Cells after Injury. Journal of Biological Chemistry, 273, 4135-4142. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Han, W.K., Alinani, A., Wu, C., Michaelson, D., Loda, M., McGovern, F.J., et al. (2005) Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell Carcinoma. Journal of the American Society of Nephrology, 16, 1126-1134. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Kuehn, E.W., Park, K.M., Somlo, S. and Bonventre, J.V. (2002) Kidney Injury Molecule-1 Expression in Murine Polycystic Kidney Disease. American Journal of Physiology-Renal Physiology, 283, F1326-F1336. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Han, W.K., Bailly, V., Abichandani, R., Thadhani, R. and Bonventre, J.V. (2002) Kidney Injury Molecule-1 (KIM-1): A Novel Biomarker for Human Renal Proximal Tubule Injury. Kidney International, 62, 237-244. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Nozaki, Y., Kinoshita, K., Yano, T., Shiga, T., Hino, S., Niki, K., et al. (2014) Estimation of Kidney Injury Molecule-1 (kim-1) in Patients with Lupus Nephritis. Lupus, 23, 769-777. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Chan, R.W., Lai, F.M., Li, E.K., Tam, L., Wong, T.Y., Szeto, C.Y., et al. (2004) Expression of Chemokine and Fibrosing Factor Messenger RNA in the Urinary Sediment of Patients with Lupus Nephritis. Arthritis & Rheumatism, 50, 2882-2890. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Rovin, B.H., Doe, N. and Tan, L.C. (1996) Monocyte Chemoattractant Protein-1 Levels in Patients with Glomerular Disease. American Journal of Kidney Diseases, 27, 640-646. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Torabinejad, S., Mardani, R., Habibagahi, Z., Roozbeh, J., Khajedehi, P., Pakfetrat, M., et al. (2012) Urinary Monocyte Chemotactic Protein-1 and Transforming Growth Factor-Β in Systemic Lupus Erythematosus. Indian Journal of Nephrology, 22, 5-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Marks, S.D., Shah, V., Pilkington, C. and Tullus, K. (2010) Urinary Monocyte Chemoattractant Protein-1 Correlates with Disease Activity in Lupus Nephritis. Pediatric Nephrology, 25, 2283-2288. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Avihingsanon, Y., Phumesin, P., Benjachat, T., Akkasilpa, S., Kittikowit, V., Praditpornsilpa, K., et al. (2006) Measurement of Urinary Chemokine and Growth Factor Messenger RNAs: A Noninvasive Monitoring in Lupus Nephritis. Kidney International, 69, 747-753. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Lema, G.P.D., Maier, H., Nieto, E., Vielhauer, V., Luckow, B., Mampaso, F., et al. (2001) Chemokine Expression Precedes Inflammatory Cell Infiltration and Chemokine Receptor and Cytokine Expression during the Initiation of Murine Lupus Nephritis. Journal of the American Society of Nephrology, 12, 1369-1382. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Kitamura, S., Maeshima, Y., Sugaya, T., Sugiyama, H., Yamasaki, Y. and Makino, H. (2004) Transforming Growth Factor-Β1 Induces Vascular Endothelial Growth Factor Expression in Murine Proximal Tubular Epithelial Cells. Nephron Experimental Nephrology, 95, e79-e86. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Hammad, A.M., Youssef, H.M. and El-Arman, M.M. (2006) Transforming Growth Factor Beta 1 in Children with Systemic Lupus Erythematosus: A Possible Relation with Clinical Presentation of Lupus Nephritis. Lupus, 15, 608-612. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Szeto, C. (2014) Urine miRNA in Nephrotic Syndrome. Clinica Chimica Acta, 436, 308-313. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Wang, G., Tam, L., Li, E., Kwan, B., Chow, K., Luk, C., et al. (2011) Serum and Urinary Free MicroRNA Level in Patients with Systemic Lupus Erythematosus. Lupus, 20, 493-500. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Aljaberi, N., Bennett, M., Brunner, H.I. and Devarajan, P. (2019) Proteomic Profiling of Urine: Implications for Lupus Nephritis. Expert Review of Proteomics, 16, 303-313. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Chun, H., Chung, J., Kim, H., Yun, J., Jeon, J., Ye, Y., et al. (2007) Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus. Journal of Clinical Immunology, 27, 461-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Jin, W. and Dong, C. (2013) IL-17 Cytokines in Immunity and Inflammation. Emerging Microbes & Infections, 2, e60. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Abdel Galil, S.M., Ezzeldin, N. and El-Boshy, M.E. (2015) The Role of Serum IL-17 and IL-6 as Biomarkers of Disease Activity and Predictors of Remission in Patients with Lupus Nephritis. Cytokine, 76, 280-287. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
何援军, 黄德东, 来晓维, 等. 狼疮性肾炎患者血清白细胞介素-17和白细胞介素-23表达及意义[J]. 中华临床免疫和变态反应杂志, 2016, 10(2): 117-124.
|
|
[65]
|
Birmingham, D.J., Bitter, J.E., Ndukwe, E.G., Dials, S., Gullo, T.R., Conroy, S., et al. (2016) Relationship of Circulating Anti-C3b and Anti-C1q IGG to Lupus Nephritis and Its Flare. Clinical Journal of the American Society of Nephrology, 11, 47-53. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Menke, J., Iwata, Y., Rabacal, W.A., Basu, R., Yeung, Y.G., Humphreys, B.D., et al. (2009) CSF-1 Signals Directly to Renal Tubular Epithelial Cells to Mediate Repair in Mice. Journal of Clinical Investigation, 119, 2330-2342. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Menke, J., Amann, K., Cavagna, L., Blettner, M., Weinmann, A., Schwarting, A., et al. (2015) Colony-Stimulating Factor-1. Journal of the American Society of Nephrology, 26, 379-389. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Bauer, J.W., Baechler, E.C., Petri, M., Batliwalla, F.M., Crawford, D., Ortmann, W.A., et al. (2006) Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus. PLOS Medicine, 3, e491. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Fu, Q., Chen, X., Cui, H., Guo, Y., Chen, J., Shen, N., et al. (2008) Association of Elevated Transcript Levels of Interferon-Inducible Chemokines with Disease Activity and Organ Damage in Systemic Lupus Erythematosus Patients. Arthritis Research & Therapy, 10, R112. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Schiffer, L., Worthmann, K., Haller, H. and Schiffer, M. (2014) CXCL13 as a New Biomarker of Systemic Lupus Erythematosus and Lupus Nephritis—From Bench to Bedside? Clinical and Experimental Immunology, 179, 85-89. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Kulkarni, O. and Anders, H.J. (2008) Chemokines in Lupus Nephritis. Frontiers in Bioscience, 13, 3312-3320. [Google Scholar] [CrossRef] [PubMed]
|